TR200103271T2 - İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi. - Google Patents

İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi.

Info

Publication number: TR200103271T2
Authority: TR; Turkey
Prior art keywords: inflammation; infection; occurs; inflammatory therapy; progression
Prior art date: 1999-05-14

Application number

TR2001/03271T

Other languages

English (en)

Turkish (tr)

Inventor

A. Anton Peter

A. Poles Michael

V. Giorgi Janis (Vefat Etm��T�R)

E. Elliott Julie

Original Assignee

The Regents Of The University Of California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-14

Filing date

2000-05-12

Publication date

2002-06-21

2000-05-12 Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California

2002-06-21 Publication of TR200103271T2 publication Critical patent/TR200103271T2/xx

Links

206010061218 Inflammation Diseases 0.000 title abstract 2
230000004054 inflammatory process Effects 0.000 title abstract 2
238000011861 anti-inflammatory therapy Methods 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
206010065764 Mucosal infection Diseases 0.000 abstract 2
230000004913 activation Effects 0.000 abstract 1
229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
239000002260 anti-inflammatory agent Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2086—IL-13 to IL-16
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Otolaryngology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Cell Biology (AREA)
Gynecology & Obstetrics (AREA)
Molecular Biology (AREA)
Reproductive Health (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicinal Preparation (AREA)

TR2001/03271T 1999-05-14 2000-05-12 İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi. TR200103271T2 (tr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13409199P	1999-05-14	1999-05-14

Publications (1)

Publication Number	Publication Date
TR200103271T2 true TR200103271T2 (tr)	2002-06-21

Family

ID=22461735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR2001/03271T TR200103271T2 (tr)	1999-05-14	2000-05-12	İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi.

Country Status (13)

Country	Link
EP (1)	EP1202620A1 (pt)
JP (1)	JP2002544210A (pt)
KR (1)	KR20020024587A (pt)
CN (1)	CN1353573A (pt)
AU (1)	AU5010800A (pt)
BR (1)	BR0010546A (pt)
CA (1)	CA2368593A1 (pt)
HK (1)	HK1047216A1 (pt)
IL (1)	IL146130A0 (pt)
MX (1)	MXPA01011606A (pt)
PL (1)	PL351710A1 (pt)
TR (1)	TR200103271T2 (pt)
WO (1)	WO2000069255A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1303265B1 (en) *	2000-07-20	2007-07-11	Lauras AS	Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids
MXPA04006572A (es) *	2002-01-10	2005-11-04	Upjohn Co	Terapia de combinacion antivirica.
AR039540A1 (es) *	2002-05-13	2005-02-23	Tibotec Pharm Ltd	Compuestos microbicidas con contenido de pirimidina o triazina
US6790867B2 (en) *	2002-05-20	2004-09-14	Schering-Plough Animal Health Corporation	Compositions and method for treating infection in cattle and swine
CN101327325A (zh)	2002-07-30	2008-12-24	奥默罗斯公司	眼科冲洗液及方法
ITMI20031311A1 (it) *	2003-06-27	2004-12-28	Indena Spa	Formulazioni per il trattamento di disturbi artrosici.
DE602004031356D1 (de) *	2003-11-21	2011-03-24	Zalicus Inc	Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
CN102002476B (zh) *	2010-08-20	2013-05-08	上海市公共卫生临床中心	一种体外培养人体黏膜活组织模型及其建立方法和应用
CN102557976B (zh) *	2010-12-15	2015-06-10	辽宁盛京制药有限公司	溴芬酸有机盐及其制备方法、其组合物及用途
EP2481751A1 (en) *	2011-01-26	2012-08-01	PharmaSurgics in Sweden AB	Human lactoferrin derived peptides
AU2013201465B2 (en)	2012-10-24	2016-03-03	Rayner Intraocular Lenses Limited	Stable preservative-free mydriatic and anti-inflammatory solutions for injection
CN104013959A (zh) *	2014-05-21	2014-09-03	郭和友	逆转录抑制剂和免疫抗体细胞三联合疗法
CN105456273A (zh) *	2014-09-02	2016-04-06	杭州雷索药业有限公司	奈韦拉平在制备抗炎药物中的应用
TWI705812B (zh)	2014-12-01	2020-10-01	奥默羅斯公司	用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
CN106176739A (zh) *	2016-08-18	2016-12-07	滨州医学院	利托那韦增强糖皮质激素抗炎作用的医药新用途
CN106176751A (zh) *	2016-08-18	2016-12-07	滨州医学院	茚地那韦增强糖皮质激素抗炎作用的医药新用途
CN106309445A (zh) *	2016-08-18	2017-01-11	滨州医学院	奈非那韦增强糖皮质激素抗炎作用的医药新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5605885A (en) *	1988-05-05	1997-02-25	Entremed, Inc.	Method for stimulating the immune system
EP0407701A3 (en) *	1989-05-15	1992-04-22	Fujisawa Pharmaceutical Co., Ltd.	Antiretroviral pyrroline and pyrrolidine sulfonic acid derivatives
US5891924A (en) *	1996-09-26	1999-04-06	Research Development Foundation	Curcumin (diferuloylmethane) inhibition of NFκB activation

2000
- 2000-05-12 MX MXPA01011606A patent/MXPA01011606A/es not_active Application Discontinuation
- 2000-05-12 JP JP2000617724A patent/JP2002544210A/ja active Pending
- 2000-05-12 IL IL14613000A patent/IL146130A0/xx unknown
- 2000-05-12 CN CN00807547A patent/CN1353573A/zh active Pending
- 2000-05-12 EP EP00932379A patent/EP1202620A1/en not_active Withdrawn
- 2000-05-12 TR TR2001/03271T patent/TR200103271T2/xx unknown
- 2000-05-12 PL PL00351710A patent/PL351710A1/xx not_active Application Discontinuation
- 2000-05-12 KR KR1020017014522A patent/KR20020024587A/ko not_active Ceased
- 2000-05-12 HK HK02109002.5A patent/HK1047216A1/zh unknown
- 2000-05-12 AU AU50108/00A patent/AU5010800A/en not_active Abandoned
- 2000-05-12 BR BR0010546-5A patent/BR0010546A/pt not_active Application Discontinuation
- 2000-05-12 WO PCT/US2000/013142 patent/WO2000069255A1/en not_active Ceased
- 2000-05-12 CA CA002368593A patent/CA2368593A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2000069255A1 (en)	2000-11-23
AU5010800A (en)	2000-12-05
KR20020024587A (ko)	2002-03-30
IL146130A0 (en)	2002-07-25
JP2002544210A (ja)	2002-12-24
MXPA01011606A (es)	2003-09-10
CA2368593A1 (en)	2000-11-23
BR0010546A (pt)	2002-03-05
HK1047216A1 (zh)	2003-02-14
PL351710A1 (en)	2003-06-02
CN1353573A (zh)	2002-06-12
EP1202620A1 (en)	2002-05-08
WO2000069255A8 (en)	2001-03-22

Publication	Publication Date	Title
TR200103271T2 (tr)	2002-06-21	İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi.
TR200200118T2 (tr)	2002-12-23	Yeni bileşimler
ECSP034568A (es)	2003-06-25	Inhibidores de metaloproteinasa del tipo pirimidin 2,4,6-triona
ATE336229T1 (de)	2006-09-15	Zusammensetzung auf der basis polymerer mizellen
CO4340688A1 (es)	1996-07-30	Derivados de quinazolina y procedimientos de uso de los mismos, como agentes contra el cancer, en los mamiferos.
HN2001000244A (es)	2003-11-07	Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
EA200500149A1 (ru)	2006-08-25	Тканевые протективные цитокины для защиты, восстановления и стимуляции реактивных клеток, тканей и органов
CY1108532T1 (el)	2014-04-09	Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
DE60038183D1 (de)	2008-04-10	Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
CY1112478T1 (el)	2015-12-09	Ενωσεις κιναζολινονης ως αντικαρκινικοι παραγοντες
CY1110013T1 (el)	2015-01-14	Συνδυασμοι για θεραπεια πολλαπλου μυελωματος
TR200101719T2 (tr)	2002-08-21	Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımı
TR200101722T2 (tr)	2001-11-21	Serivastatin ve fibratların birleşimi.
ATE413179T1 (de)	2008-11-15	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
SE0300971D0 (sv)	2003-04-03	Nitric oxide in treatment of inflammation
CY1106595T1 (el)	2012-01-25	Συνθεση πηγματος και εφαρμογη μεσω του οσχεου μιας συνθεσεως δια την θεραπευτικη αγωγη του υπογοναδισμου
TR199901413T2 (xx)	1999-08-23	Eklem iltihab� i�in yeni tedavi.
TR200201089T2 (tr)	2002-09-23	Dipiridamol veya mopidamolün fibrine bağlı mikrodolaşım bozukluklarının tedavisi
BR0209645A (pt)	2004-07-06	Oxazolo- e furopirimidinas e seu uso como medicamentos
SE9802208D0 (sv)	1998-06-22	Novel compounds
TR200102107T2 (tr)	2001-12-21	Tümör nekroz faktör antagonistleri ve endometriozda kullanımları.
TR200201071T2 (tr)	2002-08-21	Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi
DE60228544D1 (de)	2008-10-09	Triptolid-prodrugs zur krebstherapie
UY27772A1 (es)	2003-11-28	Inhibidores triariloxiariloxipirimidin-2,4,6- triona de metaloproteinasa.
IS6130A (is)	2001-10-26	Bólgueyðandi meðhöndlun fyrir bólgu tengt smit